A Pilot Trial of Unrelated Donor Hematopoietic Cell Transplantation for Children With Severe Thalassemia Using a Reduced Intensity Conditioning Regimen (The URTH Trial)
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary objective: To determine event-free survival at 1 year.
1 year
No
Shalini Shenoy, MD
Principal Investigator
Washington University Medical Center
United States: Institutional Review Board
TCRN-NMD 0901
NCT01005576
January 2010
Name | Location |
---|---|
University of Michigan | Ann Arbor, Michigan 48109-0624 |
Children's National Medical Center | Washington, District of Columbia 20010-2970 |
Children's Hospital and Research Center at Oakland | Oakland, California 94609-1809 |
Duke University | Durham, North Carolina 27710 |
Vanderbilt University | Nashville, Tennessee 37232-6305 |
Emory University | Atlanta, Georgia 30322 |
Dana Farber Cancer Institute | Boston, Massachusetts 02115 |
Washington University | St. Louis, Missouri 63110 |
The University Of North Carolina At Chapel Hill | Chapel Hill, North Carolina 27599-7235 |
Children's Memorial Hospital | Chicago, Illinois 60614 |
University of Miami | Miami, Florida 33136 |
Oregon Health and Science University | Portland, Oregon 97201 |
Ut Southwestern Medical Center | Dallas, Texas 75390 |
The Children's Hospital of Philadelphia | Philadelphia, Pennsylvania 19104 |
Methodist Healthcare System of San Antonio | San Antonio, Texas 78229 |
Regents of University of California- UCLA | Los Angeles, California 90095 |
All Children's Research Institute, Inc. | St. Petersburg, Florida 33701 |
The Research Institute at Nationwide Children's Hospital | Columbus, Ohio 43205 |